The Obestatin/Ghrelin System as a Novel Regulatory Mechanism of Iris Muscle Contraction

REFERENCES

• Zhang J V, Ren P G, Avsian-Kretchmer O, et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005; 310: 996–999
   PubMed Web of Science ®Google Scholar
• McKee K K, Tan C P, Palyha O C, et al. Cloning and characterization of two human G protein-coupled receptor genes (GPR38 and GPR39) related to the growth hormone secretagogue and neurotensin receptors. Genomics 1997; 46: 426–434
   PubMed Web of Science ®Google Scholar
• Jackson V R, Nothacker H P, Civelli O. GPR39 receptor expression in the mouse brain. Neuroreport. 2006; 17: 813–816
   PubMed Web of Science ®Google Scholar
• Dun S L, Brailoiu G C, Brailoiu E, Yang J, Chang J K, Dun N J. Distribution and biological activity of obestatin in the rat. J Endocrinol. 2006; 191: 481–489
   PubMedGoogle Scholar
• Lauwers E, Landuyt B, Arckens L, Schoofs L, Luyten W. Obestatin does not activate orphan G protein-coupled receptor GPR39. Biochem Biophys Res Commun. 2006; 351: 21–25
   PubMedGoogle Scholar
• Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999; 402: 656–660
   PubMed Web of Science ®Google Scholar
• Rocha-Sousa A, Saraiva J, Henriques-Coelho T, Falcao-Reis F, Correia-Pinto J, Leite-Moreira A F. Ghrelin as a novel locally produced relaxing peptide of the iris sphincter and dilator muscles. Exp Eye Res. 2006; 83: 1179–1187
   PubMed Web of Science ®Google Scholar
• Leite-Moreira A F, Rocha-Sousa A, Henriques-Coelho T. Cardiac, skeletal and smooth muscle regulation by ghrelin. Vitamins & Hormones 2007; 77: 208–238
   Google Scholar
• Bedendi I, Alloatti G, Marcantoni A, et al. Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln14-ghrelin. Eur J Pharmacol 2003; 476: 87–95
   PubMed Web of Science ®Google Scholar
• Soares J B, Rocha-Sousa A, Castro-Chaves P, Henriques-Coelho T, Leite-Moreira A F. Inotropic and lusitropic effects of ghrelin and their modulation by the endocardial endothelium, NO, prostaglandins, GHS-R1a and KCa channels. Peptides. 2006; 27: 1616–1623
   PubMedGoogle Scholar
• Kleinz M J, Maguire J J, Skepper J N, Davenport A P. Functional and immunocytochemical evidence for a role of ghrelin and des-octanoyl ghrelin in the regulation of vascular tone in man. Cardiovasc Res. 2006; 69: 227–235
   PubMed Web of Science ®Google Scholar
• Wiley K E, Davenport A P. Comparison of vasodilators in human internal mammary artery: Ghrelin is a potent physiological antagonist of endothelin-1. Br J Pharmacol. 2002; 136: 1146–1152
   PubMed Web of Science ®Google Scholar
• Dass N B, Munonyara M, Bassil A K, et al. Growth hormone secretagogue receptors in rat and human gastrointestinal tract and the effects of ghrelin. Neurosci 2003; 120: 443–453
   PubMed Web of Science ®Google Scholar
• Depoortere I, De Winter B, Thijs T, De Man J, Pelckmans P, Peeters T. Comparison of the gastroprokinetic effects of ghrelin, GHRP-6 and motilin in rats in vivo and in vitro. Eur J Pharmacol. 2005; 515: 160–168
   PubMedGoogle Scholar
• Lagaud G J, Young A, Acena A, Morton M F, Barrett T D, Shankley N P. Obestatin reduces food intake and suppresses body weight gain in rodents. Biochem Biophys Res Commun. 2007; 357: 264–269
   PubMedGoogle Scholar
• Moechars D, Depoortere I, Moreaux B, et al. Altered gastrointestinal and metabolic function in the GPR39-obestatin receptor-knockout mouse. Gastroenterol 2006; 131: 1131–1141
   PubMedGoogle Scholar
• Gourcerol G, St-Pierre D H, Tache Y. Lack of obestatin effects on food intake: Should obestatin be renamed ghrelin-associated peptide (GAP)?. Regul Pept 2007; 141: 1–7
   PubMedGoogle Scholar
• Camina J P, Campos J F, Caminos J E, Dieguez C, Casanueva F F. Obestatin-mediated proliferation of human retinal pigment epithelial cells: Regulatory mechanisms. J Cell Physiol. 2007; 211: 1–9
   PubMedGoogle Scholar
• Tachado S D, Akhtar R A, Abdel-Latif A A. Activation of beta-adrenergic receptors causes stimulation of cyclic AMP, inhibition of inositol trisphosphate, and relaxation of bovine iris sphincter smooth muscle. Biochemical and functional interactions between the cyclic AMP and calcium signaling systems. Invest Ophthalmol Vis Sci 1989; 30: 2232–2239
   PubMed Web of Science ®Google Scholar
• Tachado S D, Akhtar R A, Zhou C J, Abdel-Latif A A. Effects of isoproterenol and forskolin on carbachol-and fluoroaluminate-induced polyphosphoinositide hydrolysis, inositol trisphosphate production, and contraction in bovine iris sphincter smooth muscle: Interaction between cAMP and IP3 second messenger systems. Cellular Signaling. 1992; 4: 61–75
   PubMedGoogle Scholar
• Ding K H, Abdel-Latif A A. Actions of C-type natriuretic peptide and sodium nitroprusside on carbachol-stimulated inositol phosphate formation and contraction in ciliary and iris sphincter smooth muscles. Invest Ophthalmol Vis Sci. 1997; 38: 2629–2638
   PubMed Web of Science ®Google Scholar
• Yoshitomi T, Yamaji K, Ishikawa H, Ohnishi Y. Effect of pituitary adenylate cyclase-activating peptide on isolated rabbit iris sphincter and dilator muscles. Invest Ophthalmol Vis Sci 2002; 43: 780–783
   PubMedGoogle Scholar
• Yamaji K, Yoshitomi T, Usui S. Effect of somatostatin and galanin on isolated rabbit iris sphincter and dilator muscles. Exper Eye Res. 2003; 77: 609–614
   PubMedGoogle Scholar
• Gustafsson L E, Wiklund N P. Adenosine-modulation of cholinergic and non-adrenergic non-cholinergic neurotransmission in the rabbit iris sphincter. Br J Pharmacol. 1986; 88: 197–204
   PubMedGoogle Scholar
• Hayashi K, Masuda K. Effects of vasoactive intestinal polypeptide (VIP) and cyclic-AMP on the isolated sphincter pupillae muscles of the albino rabbit. Japanese J Ophthalmol 1982; 26: 437–442
   PubMedGoogle Scholar
• Marathe G K, Yousufzai S Y, Abdel-Latif A A. Mediation by prostaglandins of the stimulatory effect of substance P on cyclic AMP production in dog iris sphincter smooth muscle. Biochem Pharmacol. 1996; 52: 1261–1269
   PubMedGoogle Scholar
• Yousufzai S Y, Ali N, Abdel-Latif A A. Effects of adrenomedullin on cyclic AMP formation and on relaxation in iris sphincter smooth muscle. Invest Ophthalmol Vis Sci 1999; 40: 3245–3253
   PubMed Web of Science ®Google Scholar
• Pianka P, Oron Y, Lazar M, Geyer O. Nonadrenergic, noncholinergic relaxation of bovine iris sphincter: Role of endogenous nitric oxide. Invest Ophthalmol Vis Sci. 2000; 41: 880–886
   PubMedGoogle Scholar
• Piccone M, Littzi J, Krupin T, Stone R A, Davis M, Wax M B. Effects of neuropeptide Y on the isolated rabbit iris dilator muscle. Invest Ophthalmol Vis Sci. 1988; 29: 330–332
   PubMedGoogle Scholar
• Ueda N, Muramatsu I, Sakakibara Y, Fujiwara M. Noncholinergic, nonadrenergic contraction and substance P in rabbit iris sphincter muscle. Japanese J Pharmacol. 1981; 31: 1071–1079
   PubMedGoogle Scholar
• Gourcerol G, Tache Y. Obestatin—A ghrelin-associated peptide that does not hold its promise to suppress food intake and motility. Neurogastroenterol Motil. 2007; 19: 161–165
   PubMedGoogle Scholar